Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥15.80 - CN¥37.99
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CN¥14.11B |
EV | CN¥13.72B |
Shares Outstanding | 404.59M |
Beta | - |
Analyst Rating | BUY |
Analyst Target Price | CN¥30.17 |
P/E 2024E | 44.97x |
P/Revenue 2024E | 10.47x |
Revenue | 32.60% |
EPS | 27.30% |
Operating Cash Flow | 42.60% |
Free Cash Flow | - |
Revenue | 27.80% |
EPS | 23.70% |
Operating Cash Flow | 24.60% |
Free Cash Flow | - |
Gross Margin 2024E | 58.26% |
Net Profit Margin 2024E | 23.27% |
ROE 2024E | 14.71% |
ROCE 2023 | 17.10% |
DPS 2024E | CN¥0.20 |
Payout Ratio 2024E | 25.64% |
Div. Yield 2024E | 0.57% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Runben Biotechnology Co., Ltd.
603193
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Data Unavailable
Employees
917
Website
www.runben.comIPO Date
Headquarters
No. 3, Xinzhuang 5th Road, Guangzhou Economic and Technological Development Zone, Guangzhou, Guangdong Province, 510627, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved